An independent US expert group, US Preventive Services Task Force (USPSTF), has suggested that screening for ovarian cancer won’t of much benefit; instead its risks overshadow its advantages.

The report concerning the recommendation of the screening of the cancer was published on Tuesday; the recommendations are made only after collecting appropriate evidences, which may be in its favor or against it.

The Task Force has grade system, according to which the recommendations are classified under the A, B, C, D and I category. The recommendations are based on evidences, so evidences and even the benefits related to the product or technology helps it gain its category. Ovarian cancer screening has been classified under the D category of recommendations.

Grade D means, “The Task Force recommends against routinely providing [the service] to asymptomatic patients, and that it found at least fair evidence that [the service] is ineffective or that harms outweigh benefits”.

The findings of the report have been included in the September 11 issue of Annals of Internal Medicine. Further, the Task Force has affirmed that at present, there are no such screening methods for ovarian cancer, which can be claimed to be effective in controlling the death rate related to the cancer type.